A pilot study involving 100 COVID-19 patients set out to assess the relationship between the blood EPA+DHA levels and risk of mortality reported a strong trend and likelihood of EPA and DHA lowering the risk of death up to 75% due to COVID-19 ( Asher et al., 2021 ).
← all excerpts
Could Nutraceutical Approaches Possibly Attenuate the Cytokine Storm in COVID-19 Patients?
1
—
—